C07F 9 - Compounds containing elements of the 5th group of the periodic system

Patents for C07F 9 - Compounds containing elements of the 5th group of the periodic system (55,377)
12/2002
12/19/2002	WO2002100869A1 New napsylate salts i
12/19/2002	WO2002100868A1 Process for preparation of phosphoric esters
12/19/2002	WO2002100860A2 Heterocyclic compounds, method for preparing same and use thereof as medicines, in particular as anti-bacterial agents
12/19/2002	WO2002100831A1 4-imino-n-alkoxy or oxy-polyalkyl-piperidine compounds and their use as polymerization regulators
12/19/2002	WO2002092606A8 Fused imidazolidine derivatives, process for preparation of the same and use thereof
12/19/2002	WO2002067855A3 Enantiomers of unsaturated alkyllysophosphonocholines and use as anti-neoplastics
12/19/2002	WO2002042248A3 Naphthalene derivatives
12/19/2002	US20020193637 Process for the purification of phosphonium salts
12/19/2002	US20020193627 Prepared by neutralizing pamidronic acid with sodium compound, drying disodium pamidronate, dissolving in water, filtering sparingly soluble materials, allowing the filtrate to crystallize
12/19/2002	US20020193620 Process for the preparation of hindered phosphites
12/19/2002	US20020193619 Synthesized from o,m,or p-iodotoluene, rather than iodobenzene, therefore do not pose carcinogenic risk; one of aryl groups bonded to positive iodine ion contains methyl substituent, other contains hydroxyl-substituted alkoxy group
12/19/2002	US20020193596 Inhibitors of protein isoprenyl transferases
12/19/2002	US20020193592 Use as phase transfer catalysts, in halogen-fluorine exchange reactions and nucleophilic substitutions; bis(2-methoxyethyl)amino-tris(pyrrolidino)phosphonium chloride for example; lower dermal toxicity
12/19/2002	US20020193540 Ionically conducting materials, electrolytes and selective membranes
12/19/2002	US20020193536 Transition metal compound, polymerization catalysts for olefins, olefin polymers and process for their production
12/19/2002	US20020193353 2-hydroxymethylcyclopropylidenemethylpurines and -pyrimidines as antiviral agents
12/19/2002	US20020193348 As blood-coagulation inhibitor or an agent for therapy and prophylaxis of thrombosis or embolism, containing
12/19/2002	US20020193331 Non-naturally occurring nucleic acid compositions, their use for the preparation of formulations useful for transfecting a nucleic acid into cells and applications
12/19/2002	DE10129057A1 Verbessertes Verfahren zur Herstellung kernfluorierter Aromaten Improved process for preparing aromatic kernfluorierter
12/19/2002	CA2447730A1 Lithium p-diarylphosphinobenzenesulfonates, process for preparation of the same and use thereof
12/19/2002	CA2443718A1 4-imino-n-alkoxy or oxy-polyalkyl-piperidine compounds and their use as polymerization regulators
12/18/2002	WO2001097784A1 Process for producing phospholipid-containing drugs
12/18/2002	EP1266904A1 Improved process for preparing fluorinated aromatic compounds
12/18/2002	EP1265935A1 Polymerisation catalyst
12/18/2002	EP1265907A2 Novel aryl fructose-1,6-bisphosphatase inhibitors
12/18/2002	EP1265906A1 Fluorinated lubricant additives
12/18/2002	EP1265905A1 Il-8 receptor antagonists
12/18/2002	EP1265832A2 Separation of reaction products containing organophosphorus complexes
12/18/2002	EP1265831A2 Separation of reaction products containing organophosphorus complexes
12/18/2002	EP1265830A2 Separation of reaction products containing organophosphorus complexes
12/18/2002	EP1265695A1 Neutralization of phosphate esters, compositions based upon and methods using same
12/18/2002	EP1131392B1 Improved method for refining vegetable oil
12/18/2002	EP1098898B1 Calcium (3s) tetrahydro-3-furanyl(1s,2r)-3-[[(4-aminophenyl) sulfonyl] (isobutyl) amino] -1-benzyl-2- (phosphonooxy) propylcarbamate
12/18/2002	EP1027744B1 ESTER AS A SOLVENT IN ELECTROLYTE SYSTEMS FOR Li ION ACCUMULATORS
12/18/2002	EP1021392B1 Processes for producing hydroxyaldehydes
12/18/2002	EP0938514B1 Ordered poly(arylene vinylene) terpolymers, method for the production and the use thereof as electroluminescent materials
12/18/2002	EP0934324B1 Process for synthesizing carbapenem side chain intermediates
12/18/2002	EP0832085B1 Phosphinic acid derivatives with metallopeptidase inhibitory activity
12/18/2002	EP0778844B1 Functional terpyridine metal complexes, methods for their preparation and oligonucleotide conjugates with terpyridine metal complexes
12/18/2002	CN1385435A Process for synthesizing fosfomycin using cis-propenyl phosphonic acid as raw material
12/18/2002	CN1096464C 2,3-benzodiazepine derivatives, its preparation and intermediate and use as medicine
12/18/2002	CN1096448C Farnesyl transferase inhibitors, its preparation and medicine composition thereof
12/18/2002	CA2412888A1 Process for producing phospholipid-containing drug
12/17/2002	US6495720 Preparing trisubstituted hydroxylamines, obtained from nitroxides, which can be used in particular as radical-polymerization initiators
12/17/2002	US6495676 Nucleic acid sequence detection employing probes comprising non-nucleosidic coumarin derivatives as polynucleotide-crosslinking agents
12/17/2002	US6495641 Catalysts based on vanadium, their preparation and use in the (CO) polymerization of α-olefins
12/17/2002	US6495533 Drugs containing phosphoric acid derivatives as the active ingredient
12/12/2002	WO2002099141A1 Fluorescent quenching detection reagents and methods
12/12/2002	WO2002098886A1 Cyclic phosphazenes, process for preparing them, flame retardants containing the same as the active ingredient, and resin compositions and molded articles containing the flame retardants
12/12/2002	WO2002098885A1 Modified psma ligands and uses related thereto
12/12/2002	WO2002098851A1 Derivatives 0f n,s-substitutions n'-1 [(hetero)aryl] alkyl-n'-[hetero) aryl] methyl isothioureas, method for producing salts and bases thereof, physiologically active n,s-substitutions n'-1 [(hetero)aryl] alkyl-n'-[hetero) aryl] methyl isothioureas, a pharmaceutical composition and curing method
12/12/2002	WO2002098844A1 Method for producing perfluoroalkanesulfonic acid esters
12/12/2002	WO2002098839A1 Biphenylcarboxamides and process for preparation thereof
12/12/2002	WO2002098549A2 Compositions of alkanolamine salts of alkyl phosphate esters
12/12/2002	WO2002090313A8 Aloe-emodin derivatives and their use in the treatment of neoplastic pathologies
12/12/2002	US20020188148 Inclusion of the phosphate group in castor oil or hydrogenated castor oil or ricinoleic acid results in improved water solubility and a series of dispersants and emulsifiers that provide excellent pigment dispersing properties
12/12/2002	US20020188145 Trialkyl Group VA metal compounds
12/12/2002	US20020188127 Process for preparing imidazoquinolinamines
12/12/2002	US20020187977 Methods for restoring cognitive function following systemic stress
12/12/2002	US20020187928 Phosphinylmethyl and phosphorylmethyl succinic and glutauric acid analogs as B-secretase inhibitors
12/12/2002	US20020187542 Fatty-acid amide hydrolase
12/12/2002	CA2449060A1 Process for the preparation of compounds containing perfluoroalkanesulfonic acid groups
12/12/2002	CA2436408A1 Modified psma ligands and uses related thereto
12/11/2002	EP1263866A1 Use of bridged halogenated aryl phosphates as flameproofing agents
12/11/2002	EP1263810A2 Polymerization of olefins
12/11/2002	EP1263771A2 Chemoselective ligation by use of a phosphine
12/11/2002	EP1263763A2 Tubulin binding ligands and corresponding prodrug constructs
12/11/2002	EP1263752A2 Lpa receptor agonists and antagonists and methods of use
12/11/2002	EP1263747A1 1,5-benzothiazepines and their use as hypolipidaemics
12/11/2002	EP1263741A1 Bifunctional chelating agent
12/11/2002	EP1117668B1 Fluorous phosphines and process for their preparation
12/11/2002	EP1100805B1 Medicine nitrate salts
12/11/2002	EP1084152B1 Tridentate ligand-containing metal catalyst complexes for olefin polymerization
12/11/2002	EP1056755B1 Fungicides
12/11/2002	EP0966436B1 Aryl sulfonamides and analogues thereof and their use in the treatment of neurodegenerative diseases
12/11/2002	CN1385036A Communications system
12/11/2002	CN1384107A Low temperature and low pressure phosphine alkane trap and phosphine alkane preparing process
12/11/2002	CN1384106A Phosphonio salt and its prepn and use as well as phosphine for preparing the phosphonio salt and its prepn
12/11/2002	CN1384100A Benzo-1,3-dioxole and benzofuran substituted pentazane derivative
12/10/2002	US6492557 A bis(aminostyryl)naphthalene compound represented by the formula (6) below. the compound of the present invention emits intense yellow to red light depending on the substituent groups introduced therein. therefore, it is organic light
12/10/2002	US6492553 A method for preparing a n-((aliphatic or aromatic)carbonyl) )-2-aminoacetamide compound, and for preparing a cyclized compound therefrom, as well as novel resin bound intermediate compounds that are useful for preparing such compounds.
12/10/2002	US6492540 Enclosed are high refractive index and low birefringence organic/inorganic hybrid materials useful for optical applications. they are prepared from solventless metal aliphatic acryl alkoxides. the metal acryl alkoxides are
12/10/2002	US6492474 Aluminum phosphinimine complexes
12/10/2002	US6492408 Peptidomimetic inhibitors of intercellular adhesion molecules binding to leukointegrins, such as lfa-1 and mac-1
12/05/2002	WO2002097393A2 Cleavable surfactants and methods of use thereof
12/05/2002	WO2002096918A1 Purification process
12/05/2002	WO2002096917A1 Purification process and intermediates
12/05/2002	WO2002096916A1 Process for phosphorylation
12/05/2002	WO2002096910A1 Cytotoxins, prodrugs, linkers and stabilizers useful therefor
12/05/2002	WO2002096905A1 Thiazole compounds useful as inhibitors of protein kinases
12/05/2002	WO2002096898A2 Process for the preparation of prostaglandins and analogues thereof
12/05/2002	WO2002096897A1 PHOSPHINYLMETHYL AND PHOSPHORYLMETHYL SUCCINIC AND GLUTARIC ACID ANALOGS AS β-SECRETASE INHIBITORS
12/05/2002	WO2002096888A1 Cdk inhibiting pyrimidines, production thereof and their use as medicaments
12/05/2002	WO2002096857A1 Novel retinoid derivatives and methods for producing said compounds and an anti-cancer pharmaceutical composition comprising said compounds
12/05/2002	WO2002034389A3 Dendritic macromolecules for metal-ligand catalyzed processes
12/05/2002	US20020183534 Reaction of a bismuth hydroxide, bismuth oxide or bismuth oxynitrate with a dithiocarbamate or a dithiophosphoric acid; extreme pressure and/or antiwear agent
12/05/2002	US20020183521 Fluorous phosphines and phosphine oxides
12/05/2002	US20020183512 Compounds for use in treatment of cancer
12/05/2002	US20020183371 Oxazolidinone combinatorial libraries, compositions and methods of preparation
12/05/2002	US20020183327 For use as analgesics

1 ... 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 ... 554